Warfarin Therapy in the HIV Medical Home Model: Low Rates of Therapeutic Anticoagulation Despite Adherence and Differences in Dosing Based on Specific Antiretrovirals

No abstract is available for this paper.

• Publication year

  2012

• Venue

  AIDS Patients Care and STDs

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/apc.2012.0068PMID 22742455PMCID PMC3462408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

  2010cited by this paper
• The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals

  2010cited by this paper
• Warfarin–Antiretroviral Interactions

  2009cited by this paper
• Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

  2009cited by this paper
• Ryan White: an unintentional home builder.

  2009cited by this paper
• HIV-associated neurocognitive disease continues in the antiretroviral era.

  2008cited by this paper
• Challenge of coadministering antiretroviral therapy and oral anticoagulants in HIV-positive patients.

  2008cited by this paper
• Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Venous Thromboembolism in Patients With HIV/AIDS: A Case-Control Study

  2008cited by this paper
• Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment.

  2008cited by this paper
• Human Immunodeficiency Virus Infection and Risk of Venous Thromboembolism

  2008cited by this paper
• Review: Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era

  2008cited by this paper
• Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Risk factors for nonadherence to warfarin: results from the IN‐RANGE study

  2008cited by this paper
• Antiphospholipid antibodies in HIV-positive patients

  2007cited by this paper
• Effect of study setting on anticoagulation control: a systematic review and metaregression.

  2006cited by this paper
• Unusual Thromboses Associated with Protein S Deficiency in Patients with Acquired Immunodeficiency Syndrome: Case Reports and Review of the Literature

  2005cited by this paper
• Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series.

  2004cited by this paper
• Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs

  2001cited by this paper
• Characteristics of Anticoagulant Therapy and Comorbidity Related to Overanticoagulation

  2001cited by this paper
• AIDS and Thrombosis: Retrospective Study of 131 HIV-Infected Patients

  2001cited by this paper
• HIV/AIDS and the Risk of Deep Vein Thrombosis: A Study of 45 Patients with Lower Extremity Involvement

  2001cited by this paper
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

  2001cited by this paper
• Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project.

  2000cited by this paper
• Epidemiology of thrombosis in HIV-infected individuals

  2000cited by this paper
• GEECAT and GEEGOR: computer programs for the analysis of correlated categorical response data.

  1999cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Potential Interaction Involving Warfarin and Ritonavir

  1998cited by this paper
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Longitudinal data analysis for discrete and continuous outcomes.

  1986cited by this paper

• Antiviral Drugs in HIV and Cardiovascular Disease: Mechanistic Insights and Clinical Implications.

  2026cites this paper
• Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants.

  2025cites this paper
• Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities

  2023cites this paper
• Venous thromboembolism in viral diseases: A comprehensive literature review

  2023cites this paper
• The Youngbloods. Get Together. Hypercoagulation, Complement, and NET Formation in HIV/SIV Pathogenesis

  2022cites this paper
• Elevated Risk of Venous Thromboembolism in People Living with HIV

  2022cites this paper
• Venous thromboembolic disease in adults admitted to hospital in a setting with a high burden of HIV and TB

  2021cites this paper
• Surgical Decision-Making in Multivalvular Heart Disease: A Holistic Approach

  2020cites this paper
• Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda

  2020cites this paper
• Venous thromboembolism in people living with HIV infection (PWH).

  2020cites this paper
• Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice

  2019influential citation
• Deep Venous Thrombosis in HIV Infected Patients: Case Report and Review

  2019cites this paper
• British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism

  2018cites this paper
• The therapeutic effect of fraxetin on ethanol‐induced hepatic fibrosis by enhancing ethanol metabolism, inhibiting oxidative stress and modulating inflammatory mediators in rats

  2018cites this paper
• British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE)

  2018cites this paper
• CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation

  2017cites this paper
• Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and Warfarin: Twelve-Week Post-treatment Follow-up

  2017cites this paper
• Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya

  2017cites this paper
• Are we successfully managing cardiovascular disease in people living with HIV?

  2017cites this paper
• Use of direct oral anticoagulants for treatment of atrial fibrillation in patients with HIV: a review

  2017cites this paper
• Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice

  2017cites this paper
• Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and Warfarin

  2016cites this paper
• The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population.

  2016cites this paper
• Venous thromboembolism among HIV-positive patients and anticoagulation clinic outcomes integrated within the HIV primary care setting

  2015cites this paper
• Exploring the Medical Home in Ryan White HIV Care Settings: A Pilot Study

  2014cites this paper
• Drug Interactions and Antiretroviral Drug Monitoring

  2014cites this paper
• The hepatoprotective effect of fraxetin on carbon tetrachloride induced hepatic fibrosis by antioxidative activities in rats.

  2013cites this paper
• Conformity of Pediatric/Adolescent HIV Clinics to the Patient-Centered Medical Home Care Model

  2013cites this paper
• The role of competitive binding to human serum albumin on efavirenz-warfarin interaction: a nuclear magnetic resonance study.

  2013cites this paper